India caps prices of 50 CV and diabetes drugs

India's National Pharmaceutical Pricing Authority ( NPPA) Januvia sitagliptin from Merck & Co. Inc. (NYSE:MRK) and Volibo voglibose

Read the full 186 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE